Spots Global Cancer Trial Database for bmt
Every month we try and update this database with for bmt cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma | NCT04402138 | Mantle Cell Lym... | Acalabrutinib | 18 Years - | SCRI Development Innovations, LLC | |
| Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients | NCT00386373 | Leukemia | Imatinib Mesyla... | 16 Years - | M.D. Anderson Cancer Center | |
| Nutritional Assessment Intervention to Improve Cancer-Related Fatigue | NCT00507260 | Leukemia Lymphoma Fatigue | Food Record Nutritional Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients | NCT01015261 | Acute Lymphobla... | Bone Marrow Tra... Chemotherapy | 16 Years - 50 Years | Tehran University of Medical Sciences | |
| Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT | NCT03066466 | Acute Myeloid L... Acute Lymphocyt... Myelodysplastic... | Atorvastatin Methotrexate Tacrolimus | 18 Years - 75 Years | Loyola University | |
| Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL | NCT03042585 | Relapsed Non Ho... Refractory Non-... | Total body irra... | 18 Years - | Loyola University | |
| Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia | NCT02665065 | Acute Myeloid L... Leukemia, Acute... Myeloid Leukemi... Leukemia, Myelo... Acute Myelogeno... Leukemia, Acute... Myelogenous Leu... AML Bone Marrow Tra... | Iomab-B Conventional Ca... HCT | 55 Years - | Actinium Pharmaceuticals | |
| Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma | NCT04402138 | Mantle Cell Lym... | Acalabrutinib | 18 Years - | SCRI Development Innovations, LLC | |
| Post Transplant Donor Lymphocyte Infusion | NCT00167180 | Leukemia, Myelo... Lymphomas Multiple Myelom... Myelodysplastic... Leukemia, Lymph... Leukemia, Lymph... AML | Donor Lymphocyt... Induction Chemo... | 1 Year - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD | NCT00524784 | Graft Versus Ho... Hematological M... | ApoCell | 18 Years - 60 Years | Hadassah Medical Organization | |
| Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma | NCT00427765 | Multiple Myelom... Lymphoma | Busulfan Melphalan | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients | NCT00824993 | Hematological M... | Ibandronate Vitamin Supplem... | 18 Years - | M.D. Anderson Cancer Center | |
| A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma | NCT01171092 | Malignant Lymph... Autologous Tran... | bortezomib and ... | 18 Years - | University of Kansas Medical Center | |
| Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma | NCT00574626 | Lymphoma | PBSCT Bone Marrow Tra... | 16 Years - 65 Years | University of Nebraska | |
| A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma | NCT01171092 | Malignant Lymph... Autologous Tran... | bortezomib and ... | 18 Years - | University of Kansas Medical Center | |
| Post Transplant Donor Lymphocyte Infusion | NCT00167180 | Leukemia, Myelo... Lymphomas Multiple Myelom... Myelodysplastic... Leukemia, Lymph... Leukemia, Lymph... AML | Donor Lymphocyt... Induction Chemo... | 1 Year - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma | NCT04402138 | Mantle Cell Lym... | Acalabrutinib | 18 Years - | SCRI Development Innovations, LLC | |
| Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL | NCT03042585 | Relapsed Non Ho... Refractory Non-... | Total body irra... | 18 Years - | Loyola University | |
| Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies | NCT06398457 | Hematologic Mal... Bone Marrow Tra... Acute Myeloid L... Myelodysplastic... Acute Lymphobla... Multiple Myelom... Aplastic Anemia Lymphoma Non Hodgkin Lym... Hodgkin Lymphom... Chronic Myeloid... Myelofibrosis | Darzalex Faspro... JH-DSA Semi-Qua... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
